Tony Butler
Stock Analyst at Rodman & Renshaw
(0.96)
# 3,590
Out of 4,784 analysts
106
Total ratings
31.37%
Success rate
-14.14%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tony Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRA Atara Biotherapeutics | Initiates: Buy | $25 | $6.53 | +282.85% | 2 | Dec 20, 2024 | |
| HURA TuHURA Biosciences | Initiates: Buy | $11 | $3.53 | +211.61% | 1 | Dec 19, 2024 | |
| BMEA Biomea Fusion | Upgrades: Buy | $18 | $2.30 | +682.61% | 4 | Sep 26, 2024 | |
| MURA Mural Oncology | Initiates: Buy | $15 | $1.18 | +1,171.19% | 1 | Jun 28, 2024 | |
| LPTX Leap Therapeutics | Initiates: Buy | $8 | $0.32 | +2,426.85% | 1 | Jun 28, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $16 | $0.51 | +3,019.52% | 5 | Aug 10, 2023 | |
| ADAP Adaptimmune Therapeutics | Reiterates: Buy | $10 | $0.21 | +4,754.37% | 8 | Aug 10, 2023 | |
| FATE Fate Therapeutics | Reiterates: Buy | $10 | $0.85 | +1,077.44% | 4 | Aug 9, 2023 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $75 | $36.99 | +102.76% | 8 | Aug 8, 2023 | |
| MRUS Merus | Reiterates: Buy | $35 | $44.61 | -21.54% | 7 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $60 | $2.40 | +2,400.00% | 5 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $1.53 | +749.67% | 6 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $8.97 | +457.41% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.55 | +867.74% | 8 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.37 | +6,597.03% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.06 | +1,315.09% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.24 | +4,089.36% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $1.99 | +754.27% | 2 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.3 → $166 | $1.60 | +10,275.00% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $10.39 | +477.48% | 4 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.20 | +3,979.55% | 4 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $0.55 | +990.91% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $9 | $0.30 | +2,900.00% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $1.98 | +1.01% | 6 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $17 | $0.06 | +26,629.56% | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $3.97 | +277.83% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $10 | $1.27 | +687.40% | 2 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.99 | +653.77% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $8.07 | +1,263.07% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.50 | +15,932.06% | 1 | Mar 2, 2020 |
Atara Biotherapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $25
Current: $6.53
Upside: +282.85%
TuHURA Biosciences
Dec 19, 2024
Initiates: Buy
Price Target: $11
Current: $3.53
Upside: +211.61%
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $2.30
Upside: +682.61%
Mural Oncology
Jun 28, 2024
Initiates: Buy
Price Target: $15
Current: $1.18
Upside: +1,171.19%
Leap Therapeutics
Jun 28, 2024
Initiates: Buy
Price Target: $8
Current: $0.32
Upside: +2,426.85%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $0.51
Upside: +3,019.52%
Adaptimmune Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $10
Current: $0.21
Upside: +4,754.37%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $0.85
Upside: +1,077.44%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $36.99
Upside: +102.76%
Merus
Aug 8, 2023
Reiterates: Buy
Price Target: $35
Current: $44.61
Upside: -21.54%
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $2.40
Upside: +2,400.00%
Aug 7, 2023
Reiterates: Buy
Price Target: $13
Current: $1.53
Upside: +749.67%
Aug 3, 2023
Reiterates: Buy
Price Target: $50
Current: $8.97
Upside: +457.41%
Aug 3, 2023
Reiterates: Buy
Price Target: $15
Current: $1.55
Upside: +867.74%
Aug 2, 2023
Reiterates: Buy
Price Target: $25
Current: $0.37
Upside: +6,597.03%
Jul 31, 2023
Initiates: Buy
Price Target: $15
Current: $1.06
Upside: +1,315.09%
Jul 12, 2023
Reiterates: Buy
Price Target: $10
Current: $0.24
Upside: +4,089.36%
Jul 7, 2023
Reiterates: Buy
Price Target: $17
Current: $1.99
Upside: +754.27%
Jul 3, 2023
Reiterates: Buy
Price Target: $8.3 → $166
Current: $1.60
Upside: +10,275.00%
Jun 7, 2023
Reiterates: Buy
Price Target: $60
Current: $10.39
Upside: +477.48%
Jun 5, 2023
Reiterates: Buy
Price Target: $8
Current: $0.20
Upside: +3,979.55%
Jun 1, 2023
Assumes: Buy
Price Target: $6
Current: $0.55
Upside: +990.91%
Jun 1, 2023
Assumes: Buy
Price Target: $9
Current: $0.30
Upside: +2,900.00%
May 30, 2023
Maintains: Hold
Price Target: $5 → $2
Current: $1.98
Upside: +1.01%
May 25, 2023
Assumes: Buy
Price Target: $17
Current: $0.06
Upside: +26,629.56%
Jan 5, 2023
Initiates: Buy
Price Target: $15
Current: $3.97
Upside: +277.83%
Feb 17, 2022
Downgrades: Neutral
Price Target: $30 → $10
Current: $1.27
Upside: +687.40%
Nov 19, 2021
Initiates: Buy
Price Target: $15
Current: $1.99
Upside: +653.77%
Jun 28, 2021
Maintains: Buy
Price Target: $80 → $110
Current: $8.07
Upside: +1,263.07%
Mar 2, 2020
Initiates: Buy
Price Target: $80
Current: $0.50
Upside: +15,932.06%